Mental Health Clinics in Warren, MI Accepting Medicare
88 Mental Health Clinics found. Showing 81 - 88
 Altruistic Collective Experience Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 7177 Miller Dr, Suite C, Warren, MI 48092 Phone: 313-334-9401 |
Social Worker Group Social Worker Medicare: Not Enrolled in Medicare Practice Location: 28800 Ryan Rd, Suite 320, Warren, MI 48092 Phone: 586-620-8100 Fax: 866-227-7418 |
Childrens Home Of Detroit Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 6902 Chicago Rd, Warren, MI 48092 Phone: 586-939-4940 |
Associated Clinicians Of Michigan Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 30521 Schoenherr Rd Ste 200, Warren, MI 48088 Phone: 313-404-1195 |
Bouharb Counseling Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 2630 Dundee Dr, Warren, MI 48092 Phone: 210-379-1101 Fax: 210-379-1101 |
Lakeside Neurology P C Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 28573 Schoenherr Rd, Warren, MI 48088 Phone: 586-777-3375 Fax: 586-777-3380 |
Premier Care Warren Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 23700 Van Dyke Ave, Warren, MI 48089 Phone: 586-758-6670 Fax: 586-758-0243 |
Behavioral Physician Billing Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 4050 E 12 Mile Rd, Warren, MI 48092 Phone: 586-261-2266 Fax: 586-261-3628 |
News Archive
Experimental compound reduces joint inflammation in animal models of rheumatoid arthritis
An experimental compound synthesized and developed by scientists from the Florida campus of The Scripps Research Institute has the capacity to significantly reduce joint inflammation in animal models of rheumatoid arthritis, an autoimmune disease that affects more than two million Americans.
Promethera presents new preclinical NASH-Fibrosis data from HepaStem program at AASLD meeting
Promethera Biosciences SA, a world-leading cell therapy and regenerative medicine company targeting liver diseases, today announced the presentation of new preclinical NASH-Fibrosis data from its proprietary HepaStem program, demonstrating a beneficial effect of HepaStem in a nonalcoholic steatohepatitis (NASH) mouse model and confirming Hepastem's unique and multifaceted mode of action.
Research shows novel approach for treatment of myocardial infarction
Myocardial infarction - commonly known as a heart attack - is still one of the main causes of death. According to the Federal Statistical Office, more than 49,00 people died of its consequences.
Axsun Technologies reports successful testing of novel OCT imaging integrated light source architecture
Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation, today announced the initial development and successful testing of a novel integrated light source architecture for OCT imaging. Axsun believes this proprietary optical engine design raises the bar on imaging speed and overcomes fundamental limitations of laser-based designs for swept source OCT light sources.
ISS recommends Illumina shareholders to vote against Roche's nominees
Roche released the following statement in response to a report issued by Institutional Shareholder Services recommending that shareholders of Illumina, Inc. vote against the election of Roche's independent director nominees to Illumina's Board of Directors.
› Verified 7 days ago